Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...
Sanofi says integrated continuous purification is a “universal solution” for downstream processing as it prepares for ...
Allogeneic cell therapies offer scalability but require expanded infrastructure to build a viable commercial foundation ...
Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large ...
University students attended Biotech Week Boston Campus to learn about career options in a volatile biopharma industry and ...
Dan is currently a trade media relations expert at Sartorius, and he formerly led the news domain of Bioprocess International ...
Drug sponsors seek to capitalize on opportunities created by streamlined regulations for biosimilar characterization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results